Beneficial effects of L‑arginine on 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine‑induced neuronal degeneration in substantia nigra of Balb/c mice

L‑arginine has been recently investigated and proposed to reduce neurological damage after various experimental models of neuronal cellular damage. In this study, we aim to evaluate the beneficial effects of L‑arginine administration on the numerical density of dark neurons (DNs) in the substantia nigra pars compacta (SNc) of Balb/c mice subjected to 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine (MPTP) administration.

Male Balb/c mice were randomly divided into 4 groups (n = 7 each): MPTP only; saline only (control); MPTP + L‑arginine; and L‑arginine only. The animals were infused intranasally with a single intranasal administration of the proneurotoxin MPTP (1 mg/nostril). L‑arginine (300 mg/kg) was administrated intraperitoneally once daily for 1‑week starting from 3 days after MPTP administration. Cavalieri principle method was used to estimate the numerical density of DNs in the SNc of different studied groups.

Twenty days following MPTP administration, the number of DNs was significantly increased when compared to sham‑control and L‑arginine‑control groups (P < 0.05). Nevertheless, our results showed that L‑arginine administration significantly decreased the numerical density of DNs in SNc of mice.

This investigation provides new insights in experimental models of Parkinson’s disease, indicating that L‑arginine represents a potential treatment agent for dopaminergic neuron degeneration in SNc observed in Parkinson’s disease patients.